Plasma profile of pro‐inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co‐morbidity
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The treatment for cocaine use constitutes a clinical challenge because of the lack of appropriate therapies and the high rate of relapse. Recent evidence indicates that the immune system might be involved in the pathogenesis of cocaine addiction and its co‐morbid psychiatric disorders. This work examined the plasma pro‐inflammatory cytokine and chemokine profile in abstinent cocaine users (n = 82) who sought outpatient cocaine treatment and age/sex/body mass‐matched controls (n = 65). Participants were assessed with the diagnostic interview P sychiatric R esearch I nterview for S ubstance and M ental D iseases according to the D iagnostic and S tatistical M anual of M ental D isorders, F ourth E dition, T ext R evision (DSM‐IV‐TR). Tumor necrosis factor‐alpha, chemokine (C‐C motif) ligand 2/monocyte chemotactic protein‐1 and chemokine (C‐X‐C motif) ligand 12 (CXCL 12)/stromal cell‐derived factor‐1 (SDF‐1) were decreased in cocaine users, although all cytokines were identified as predictors of a lifetime pathological use of cocaine. Interleukin‐1 beta (IL‐1β), chemokine (C‐X 3‐C motif) ligand 1 (CX3CL 1)/fractalkine and CXCL 12/SDF‐1 positively correlated with the cocaine symptom severity when using the DSM‐IV‐TR criteria for cocaine abuse/dependence. These cytokines allowed the categorization of the outpatients into subgroups according to severity, identifying a subgroup of severe cocaine users (9–11 criteria) with increased prevalence of co‐morbid psychiatric disorders [mood (54%), anxiety (32%), psychotic (30%) and personality (60%) disorders]. IL‐1β was observed to be increased in users with such psychiatric disorders relative to those users with no diagnosis. In addition to these clinical data, studies in mice demonstrated that plasma IL‐1β, CX3CL 1 and CXCL 12 were also affected after acute and chronic cocaine administration, providing a preclinical model for further research. In conclusion, cocaine exposure modifies the circulating levels of pro‐inflammatory mediators. Plasma cytokine/chemokine monitoring could improve the stratification of cocaine consumers seeking treatment and thus facilitate the application of appropriate interventions, including management of heightened risk of psychiatric co‐morbidity. Further research is necessary to elucidate the role of the immune system in the etiology of cocaine addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · cited 4×
“In fact, recent studies indicate glial involvement in synaptic remodeling is mediated through cytokines, which can affect both synaptic functions and spine morphology in neurons (Boulanger 2009; Paolicelli et al. 2011).”
BackgroundInfluentialInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“Substantial evidence indicates inflammation as a common mechanism for the development of cardiovascular disease, diabetes, cancer, etc, but also in neuropsychiatric disease (Miller et al. 2009; Stuart & Baune 2014).”
BackgroundRobins, L. N. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360017003 · Cited by 2,909 · cited 1×
“Control subjects were initially evaluated by PRISM (for substance screening and abuse and dependence) and subsequently by the Spanish version of the Composite International Diagnostic Interview (CIDI) for the detection of psychiatric disorders (Robins et al. 1988).”
MethodDSM-5 criteria for substance use disorders: recommendations and rationale
Hasin, D. S., O’Brien, C. P., Auriacombe, M., Borges, G., Bucholz, K., Budney, A., Compton, W. M., Crowley, T., Ling, W., Petry, N. M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12060782 · Cited by 1,622
Immune proteins in brain development and synaptic plasticity
Boulanger, L. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.001 · Cited by 555 · cited 1×
“In fact, recent studies indicate glial involvement in synaptic remodeling is mediated through cytokines, which can affect both synaptic functions and spine morphology in neurons (Boulanger 2009; Paolicelli et al. 2011).”
BackgroundFractalkine and CX3CR1 regulate hippocampal neurogenesis in adult and aged rats
Bachstetter, A. D., Morganti, J. M., Jernberg, J., Schlunk, A., Mitchell, S. H., Brewster, K. W., Hudson, C. E., Cole, M. J., Harrison, J. K., Bickford, P. C., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.11.022 · Cited by 364
Koprich, J. B., Reske-Nielsen, C., Mithal, P., & Isacson, O. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-8 · Cited by 355
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.9.1195 · Cited by 332 · cited 9×
“When the common psychiatric disorders (DSM-IV-TR Axis I disorders and personality disorders) diagnosed with PRISM were grouped excluding substance use disorders and assessed in cocaine users, IL-1β was also significantly increased (**P 0.01) in co-morbid outpatients compared with cocaine users with no diagnosis.”
MethodInfluentialInduction of innate immune genes in brain create the neurobiology of addiction
Crews, F. T., Zou, J., & Qin, L. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.03.003 · Cited by 313 · cited 3×
“Therefore, these mediators might play a key role in developing addiction and substance use disorders because they affect the same neurotransmitters that are targeted by drugs of abuse such as cocaine (Miller 2009; Crews et al. 2011).”
Background
Cited by
Calipari, E. S., Godino, A., Peck, E. G., Salery, M., Mervosh, N. L., Landry, J. A., Russo, S. J., Hurd, Y. L., Nestler, E. J., & Kiraly, D. D. (2018) · Nature Communications · doi:10.1038/s41467-017-01881-x · Cited by 278
Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10
Moreira, F. P., Medeiros, J. R. C., Lhullier, A. C., Souza, L. D. D. M., Jansen, K., Portela, L. V., Lara, D. R., Silva, R. A. D., Wiener, C. D., & Oses, J. P. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.11.024 · Cited by 92
Namba, M. D., Leyrer-Jackson, J. M., Nagy, E. K., Olive, M. F., & Neisewander, J. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.650785 · Cited by 76
“As well, serum cytokine levels may be useful indicators for assessing the severity for CUDs and identifying effective treatment strategies, although sex differences and psychiatric comorbidity are important factors to consider (Araos et al., 2015; Pedraz et al., 2015; Maza-Quiroga et al., 2017; Pianca et al., 2017).”
BackgroundInfluentialPlasma interleukin-6 and executive function in crack cocaine-dependent women.
Levandowski, M. L., Hess, A. R. B., Grassi-Oliveira, R., & de Almeida, R. M. M. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.06.023 · Cited by 45
Metadata
- Authors
- Araos, P., Pedraz, M., Serrano, A., Lucena, M., Barrios, V., García‐Marchena, N., Campos‐Cloute, R., Ruiz, J. J., Romero, P., Suárez, J., Baixeras, E., de la Torre, R., Montesinos, J., Guerri, C., Rodríguez‐Arias, M., Miñarro, J., Martínez‐Riera, R., Torrens, M., Chowen, J. A., Argente, J., Mason, B. J., Pavón, F. J., & Rodríguez de Fonseca, F.
- Venue
- Addiction Biology
- Publisher
- Wiley
- Published
- 2014-05-22
- Volume
- 20
- Issue
- 4
- Pages
- 756-772
- ISSN
- 1355-6215 (ISSN-L)
- 1369-1600
- OpenAlex
- W1960047863
- Cited by
- 107
- References
- 13
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.